We sought to determine if oral vitamin D supplementation provided a neuroprotective benefit in a novel, mouse model of the cerebral demyelinating phenotype of X-linked adrenoleukodystrophy (ALD).
No takes yet. Share an insight, caveat, or question.
Haren et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: